RXMD has moved up from $.04 to $.16 in less than a month. The chart appears to have a classic “head & shoulders” formation.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
